A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors
Clinical trial NCT06710379 · RECRUITING
Trial details
- NCT number
- NCT06710379
- Sponsor
- Adcentrx Therapeutics
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-30
- Primary completion
- 2026-07-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.